Sign in Subscribe

chemo

A collection of 5 issues

RAS/BRAF wild-type patients: Maintenance strategies compared

Skip to content The CRC Digest RAS/BRAF wild-type patients: Maintenance strategies compared Three trials pooled data on left-sided, RAS/BRAF wild-type metastatic CRC to compare toxicity profiles of different maintenance approaches. (Journal of the National Cancer Institute) This content is informational only and does not constitute medical advice. Always

CRC Research Finding

Skip to content The CRC Digest ◇ GDF15 Protein Linked to Chemotherapy Resistance in Colorectal Cancer Lab studies identified GDF15 as a key molecule driving resistance to 5-fluorouracil and oxaliplatin by promoting stem cell-like properties in colorectal cancer cells; high GDF15 expression in liver metastasis specimens was associated with early recurrence

CRC Research Finding

Skip to content The CRC Digest ◆ Sequential vs. Upfront Oxaliplatin in Metastatic Colorectal Cancer: Long-Term Results (Communications Medicine) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com

Patients Describe Complex Impact of Chemo Brain on Daily Life

Skip to content The CRC Digest Patients Describe Complex Impact of Chemo Brain on Daily Life Qualitative study identifies how cognitive impairment from chemotherapy affects memory, concentration, and emotional health in colorectal cancer patients. (Journal of Health Psychology) This content is informational only and does not constitute medical advice. Always

CRC Research Finding

Skip to content The CRC Digest ♥ Study Explores Patients' Experiences with Chemotherapy-Related Cognitive Impairment Interviews with 12 colorectal cancer patients revealed how chemotherapy affects cognitive abilities, emotional well-being, and daily functioning. (Journal of Health Psychology) This content is informational only and does not constitute medical advice. Always consult your